The diagnosis was established through a core needle biopsy of the left breast, which revealed estrogen receptor (ER)-positive, progesterone receptor-positive, HER2-positive invasive breast carcinoma of no special type. The gene discussed is ESR1; the disease is invasive breast carcinoma.